Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Currently, Catalyst Biosciences stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for CBIO in coming sessions, or that it may not climb higher. Simply, it doesn't match our recommended trading systems
"To sell or not to sell", if you are holding Catalyst Biosciences shares?. Trading strategies allow us to avoid impetuous decisions based on our emotions or the buzz surrounding the market. We like very simple strategies to guide us on when is the best moment to sell our shares. Be aware that these strategies are not intended for shorting CBIO stock
As a rule of thumb, you must never hold an open trade that results in greater losses than those expected at the time of the buy. The moment to sell your stock always has to be determined by the stop-loss (automatic or manual)
In the current situation of Catalyst Biosciences there is not any eligible sell setup, so Catalyst Biosciences stock holders with operations in profit can keep their positions
Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal
In the last month, just one analyst rating was published for Catalyst Biosciences
|Jun 17th, 2020|
Catalyst Biosciences accumulates a selloff of -37.47% since its latest top last February at $8.94. Like in all downtrends, the stock oscillates drawing lower tops and bottoms. In this case, we have seen 2 consecutive lower tops
A favorite tool of many technical analysts are the moving averages, that easily show trend momentum. A moving average is the average price of a stock over a set period of time. Moving averages are usually calculated on different periods depending on the trading timeframe 21, 50, 100 and 200 days are the most usual moving averages. Learn more about Moving Averages from sources like Wikipedia and Investopedia
Investors use support and resistance levels as a way to find price points in the stock price action that may behave as obstacles, preventing the price of a stock to move in certain direction. Supports are levels where the price tends to stop as it falls. Price is more likely to "rebound" this level rather than break through it. However, if the price breaks down this level, it will probably continue declining until approaching another support level. In contrast, a resistance level is where the price may find a curb as it rises. Again, the price is more likely to "rebound" at this level, and if it finally ruptures this level, the price will rally more easily until it finds the next resistance
The current resistance levels are:
The current supports are:
This is an indicator that was introduced in the 1980s by John Bollinger. It is made up of 3 lines that are outlined superimposed on the price evolution chart:
The relative strength index (RSI) is a technical indicator used in the analysis of financial markets. Its objective is to map the current and previous strength or weakness of a stock or market based on the closing prices of a recent trading period. Oscillator indicators, such as relative strength, are intended to indicate values in the range of 0-100. The relative strength indicator is one of the best known and most widely used indicators, and it was invented by J. Welles Wilder in the late 1970s
The RSI dropped below the overbought level of 70 in late May after just crossing to the overbough zone for 1 day (weak signal). The RSI value today was 34.49. Catalyst Biosciences stock sank a 28.79% since that level was lost
CBIO had the quarterly investors call and released the Q1 report in mid-May. CBIO posted first-quarter earnings of $-0.28 per share on sales of $16.4 million. The analysts estimate was $-0.37 per share on revenue of $16.4 million.
Compared to the same quarter one year ago, EPS was $-1.26, so current EPS is a improvement of 77.78%. Looking at turnover, figures skyrocketed a 5046.54% compared to $3,180,000 same quarter last year.
CBIO is hosting the quarterly earnings call on Thursday next week. Forecasted earnings of %s per-share for this quarter is $-0.87. Earnings reporting day has an additional risk for traders as the data disclosed can soar and sink the stock price with very low volume and not respecting your buy or stop-loss orders. Check company's website to confirm time and details about the earnings call and the earnings report.